+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023 - Product Image

Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023

  • ID: 4745546
  • Report
  • December 2018
  • Region: Global
  • 111 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Quidel
  • MORE
Vendors are developing new RSV diagnostics products with increased efficiencies. These launches will contribute to the revenue of companies, which will drive the market. These advanced product launches will make products accessible for end- users and will decrease the time required for diagnostics. Analysts have predicted that the respiratory syncytial virus (RSV) diagnostics market will register a CAGR of over 9% by 2023.

Market Overview

Growing number of M&A

Core reference laboratories or large laboratories are focusing on increasing their presence in the global market through M&A. hence, large laboratories are acquiring small and medium- sized laboratories which conduct testing on infectious diseases.

Product recalls

Product recalls affect the sales and earnings of vendors for short periods and adversely impact their operations for extended periods. Therefore, the recalls of medical products or assays can limit the adoption of other systems and consumables developed by these companies.

For the detailed list of factors that will drive and challenge the growth of the respiratory syncytial virus (RSV) diagnostics market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Quidel
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2018-2023
  • Systems - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: TRENDS
  • Technological advancements
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Quidel
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global in-vitro diagnostics (IVD) market
Exhibit 03: Segments of global in-vitro diagnostics (IVD) market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 22: Systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in EMEA
Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Decision framework
Exhibit 36: Product launches by companies
Exhibit 37: Product recalls
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott - Vendor overview
Exhibit 45: Abbott - Business segments
Exhibit 46: Abbott - Organizational developments
Exhibit 47: Abbott - Geographic focus
Exhibit 48: Abbott - Segment focus
Exhibit 49: Abbott - Key offerings
Exhibit 50: Abbott - Key customers
Exhibit 51: BD - Vendor overview
Exhibit 52: BD - Business segments
Exhibit 53: BD - Organizational developments
Exhibit 54: BD - Geographic focus
Exhibit 55: BD - Segment focus
Exhibit 56: BD - Key offerings
Exhibit 57: BD - Key customers
Exhibit 58: bioMérieux - Vendor overview
Exhibit 59: bioMérieux - Business segments
Exhibit 60: bioMérieux - Organizational developments
Exhibit 61: bioMérieux - Geographic focus
Exhibit 62: bioMérieux - Segment focus
Exhibit 63: bioMérieux - Key offerings
Exhibit 64: bioMérieux - Key customers
Exhibit 65: F. Hoffmann-La Roche - Vendor overview
Exhibit 66: F. Hoffmann-La Roche - Business segments
Exhibit 67: F. Hoffmann-La Roche - Organizational developments
Exhibit 68: F. Hoffmann-La Roche - Geographic focus
Exhibit 69: F. Hoffmann-La Roche - Segment focus
Exhibit 70: F. Hoffmann-La Roche - Key offerings
Exhibit 71: F. Hoffmann-La Roche - Key customers
Exhibit 72: Quidel - Vendor overview
Exhibit 73: Quidel - Product segments
Exhibit 74: Quidel - Organizational developments
Exhibit 75: Quidel - Geographic focus
Exhibit 76: Quidel - Segment focus
Exhibit 77: Quidel - Key offerings
Exhibit 78: Quidel - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Quidel
  • MORE
Global Respiratory Syncytial Virus (RSV) Diagnostics Market 2019-2023

The analyst recognizes the following companies as the key players in the global respiratory syncytial virus (RSV) diagnostics market: Abbott, BD, bioMérieux, F. Hoffmann-La Roche, Quidel.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing focus on developing technological RSV diagnostic products will result in its growing adoption.”

According to the report, one of the major drivers for this market is the acquisition of different services by laboratories is increasing the product portfolio of companies, which is increasing their revenue and driving the market.

Further, the report states that one of the major factors hindering the growth of this market is the such strategies are essential for the growth of the global RSV diagnostics market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Quidel
Note: Product cover images may vary from those shown
Adroll
adroll